Absolute and relative vaccine effectiveness of primary and booster series of COVID-19 vaccines (mRNA and adenovirus vector) against COVID-19 hospitalizations in the United States, December 2021-April 2022
Open Forum Infectious Diseases
Open Access Publication
Rights and Permissions
Nathaniel M Lewis, Nancy Murray, Katherine Adams, Diya Surie, Manjusha Gaglani, Adit A Ginde, Tresa McNeal, Shekhar Ghamande, David J Douin, H Keipp Talbot, Jonathan D Casey, Nicholas M Mohr, Anne Zepeski, Nathan I Shapiro, Kevin W Gibbs, D Clark Files, David N Hager, Harith Ali, Matthew E Prekker, Anne E Frosch, Matthew C Exline, Michelle N Gong, Amira Mohamed, Nicholas J Johnson, Vasisht Srinivasan, Jay S Steingrub, Ithan D Peltan, Samuel M Brown, Emily T Martin, Arnold S Monto, Adam S Lauring, Akram Khan, Catherine L Hough, Laurence W Busse, William Bender, Abhijit Duggal, Jennifer G Wilson, Alexandra June Gordon, Nida Qadir, Steven Y Chang, Christopher Mallow, Carolina Rivas, Hilary M Babcock, Jennie H Kwon, James D Chappell, Natasha Halasa, Carlos G Grijalva, Todd W Rice, William B Stubblefield, Adrienne Baughman, Christopher J Lindsell, Kimberly W Hart, Jillian P Rhoads, Meredith L McMorrow, Mark W Tenforde, Wesley H Self, Manish M Patel, for the Influenza and Other Viruses in the Acutely Ill (IVY) Network, Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022, Open Forum Infectious Diseases, Volume 10, Issue 1, January 2023, ofac698, https://doi.org/10.1093/ofid/ofac698. https://academic.oup.com/ofid/article/10/1/ofac698/6966475?login=true. © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact firstname.lastname@example.org.
Lewis, Nathaniel M; Babcock, Hilary M; Kwon, Jennie H; and et al., "Absolute and relative vaccine effectiveness of primary and booster series of COVID-19 vaccines (mRNA and adenovirus vector) against COVID-19 hospitalizations in the United States, December 2021-April 2022." Open Forum Infectious Diseases. 10, 1. ofac698 (2023).
ICTS (Institute of Clinical and Translational Sciences)
Supplemental material is available for this article at publisher site.